Top Back to top

Elderly AML: A randomised Phase III study comparing conventional chemotherapy to low dose total body irradiation-based conditioning and hematopoietic stem cell transplantation from related and unrelated donors as consolidation therapy for older patients with AML in 1st complete remission

Acute Leukemia Working Party (ALWP)
Numéro de l'étude:
2007-003514-34
Type de traitement à base de cellules souches:
 
Maladies:
Acute Myeloid Leukaemia (AML)
Titre court:
HSCT vs CT in Elderly AML
Objectif principal:
Efficacy of allogeneic related or unrelated heamtopoietic cell transplantation (HCT) after reduced intensityconditioning as a consolidation treatment for elderly patietns with AML in complete remission
Principaux critères d'inclusion:
>=60, <=75 years old
Pays:
Australie
Autriche
Belgique
France
Allemagne
Pays-Bas
Suisse
Investigateur principal:
Dietger Niederwieser
Coordinateur EBMT de l'étude:
Ruzena Uddin